Goldman Sachs
MOR

Goldman Sachs’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Goldman Sachs’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-636,016
Closed -$11.6M – 6009
2024
Q1 		$11.5M Buy
636,016
+360,079
+130% +$5.32M ﹤0.01% 2351
2023
Q4 		$2.73M Buy
275,937
+236,171
+594% +$1.73M ﹤0.01% 3678
2023
Q3 		$267K Buy
39,766
+9,766
+33% +$75.2K ﹤0.01% 4946
2023
Q2 		$224K Sell
30,000
-399
-1% -$2.43K ﹤0.01% 5138
2023
Q1 		$120K Buy
30,399
+399
+1% +$1.76K ﹤0.01% 5428
2022
Q4 		$107K Sell
30,000
-13
-0% -$58 ﹤0.01% 5466
2022
Q3 		$151K Buy
30,013
+13
+0% +$67 ﹤0.01% 5574
2022
Q2 		$145K Sell
30,000
-6,411
-18% -$35.4K ﹤0.01% 5747
2022
Q1 		$247K Sell
36,411
-4,481
-11% -$33.1K ﹤0.01% 5767
2021
Q4 		$385K Buy
40,892
+9,577
+31% +$102K ﹤0.01% 5537
2021
Q3 		$368K Sell
31,315
-7,862
-20% -$114K ﹤0.01% 5379
2021
Q2 		$754K Buy
39,177
+9,177
+31% +$196K ﹤0.01% 4962
2021
Q1 		$654K Hold
30,000
– – ﹤0.01% 4921
2020
Q4 		$850K Buy
+30,000
New +$822K ﹤0.01% 4296
2020
Q3 		– Sell
-7,402
Closed -$234K – 5579
2020
Q2 		$234K Buy
+7,402
New +$216K ﹤0.01% 4732
2020
Q1 		– Sell
-8,184
Closed -$292K – 5626
2019
Q4 		$292K Sell
8,184
-56,822
-87% -$1.7M ﹤0.01% 4762
2019
Q3 		$1.79M Buy
+65,006
New +$1.86M ﹤0.01% 3617

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs's MOR Position: Q2 2024 in Review

Goldman Sachs sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2024, closing a stake of 636,016 shares — an estimated $11.6M sold.

Goldman Sachs first reported a position in MOR in Q3 2019 and held it in 17 quarters. The position peaked at $11.5M in Q1 2024. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Goldman Sachs reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 636,016 MorphoSys AG American Depositary Shares shares in Q2 2024, an estimated $11.6M.
  • Goldman Sachs first reported a position in MorphoSys AG American Depositary Shares in Q3 2019 and held it in 17 quarters.
  • Goldman Sachs's MorphoSys AG American Depositary Shares position peaked at $11.5M in Q1 2024.
  • 26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.